Blue Dart Announces Leadership Transition

Balfour Manuel will retire as Managing Director effective November 29, 2026.

R.S. Subramanian has been appointed as the incoming Managing Director starting November 30, 2026.

Reader Takeaway: Orderly leadership change with a strategic transition period ensures stability for logistics operations and shareholders.

What just happened

Blue Dart Express Ltd has formally announced a top-level leadership transition. Current Managing Director, Balfour Manuel, has requested early superannuation, which the company’s Board has approved. The Board has also waived his six-month notice period. To maintain institutional continuity, Mr. Manuel will serve as a Senior Strategic Advisor to the Managing Director through May 15, 2027.

The incoming leadership

The Board has appointed R.S. Subramanian as the new Managing Director. His term is set from November 30, 2026, to May 25, 2030, pending shareholder and statutory approvals. Mr. Subramanian currently serves as the Managing Director of DHL Express India and is already a Non-Executive Director on the Blue Dart Board.

Background of the incoming MD

With over 30 years of experience, Mr. Subramanian is a veteran of the service and product-led sectors. Prior to his long tenure at DHL Express India, he spent 14 years at Hindustan Unilever Ltd. He holds an Industrial Engineering degree and a Master’s in Management from IIM Bangalore. His expertise spans business strategy, marketing, and customer management, which he has utilized to drive market growth at DHL since 2010.

What changes now

The company is entering a structured succession period. While the leadership change is effective late in 2026, the ongoing involvement of Mr. Manuel as an advisor indicates a focus on minimizing operational friction. Shareholders should look for upcoming notices regarding the formal approval process for Mr. Subramanian’s appointment.

What to track next

Investors should watch for the shareholder meeting dates and official filings regarding the necessary statutory clearances for the new MD’s appointment.